| Stage | BX | % of rev | HLNE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.0B | 100.00% | $204M | 100.00% | BX ×24.67 |
| Gross profit | $5.0B | 100.00% | $127M | 62.11% | BX +37.9pp |
| Operating income | $2.7B | 52.90% | $86M | 42.23% | BX +10.7pp |
| Pre-tax income | $2.8B | 55.68% | $179M | 87.37% | HLNE +31.7pp |
| Net income | $2.4B | 46.71% | $149M | 72.85% | HLNE +26.1pp |
| Stage | BX | HLNE | Gap · A − B |
|---|---|---|---|
| Revenue | $5.0B100.00% | $204M100.00% | BX ×24.67 |
| Gross profit | 100.00%$5.0B | 62.11%$127M | BX +37.9pp |
| Operating income | 52.90%$2.7B | 42.23%$86M | BX +10.7pp |
| Pre-tax income | 55.68%$2.8B | 87.37%$179M | HLNE +31.7pp |
| Net income |
| 46.71%$2.4B |
| 72.85%$149M |
| HLNE +26.1pp |
No shared counterparties.